NCT07342517 2026-03-17
RESCUE
Relmada Therapeutics, Inc.
Phase 3 Withdrawn
Relmada Therapeutics, Inc.
Universidad Europea de Canarias
Vanderbilt-Ingram Cancer Center
Centre Hospitalier Universitaire, Amiens
Washington University School of Medicine
Stanford University